Callan Family Office LLC Makes New Investment in Houlihan Lokey, Inc. (NYSE:HLI)

Callan Family Office LLC bought a new position in Houlihan Lokey, Inc. (NYSE:HLI) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 1,413 shares of the financial services provider’s stock, valued at approximately $245,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Private Trust Co. NA acquired a new position in shares of Houlihan Lokey in the fourth quarter worth about $29,000. Financial Life Planners purchased a new stake in shares of Houlihan Lokey in the fourth quarter worth approximately $33,000. Golden State Wealth Management LLC purchased a new stake in shares of Houlihan Lokey in the fourth quarter worth approximately $53,000. VisionPoint Advisory Group LLC purchased a new stake in shares of Houlihan Lokey in the fourth quarter worth approximately $62,000. Finally, First Horizon Advisors Inc. lifted its position in shares of Houlihan Lokey by 81.5% in the third quarter. First Horizon Advisors Inc. now owns 441 shares of the financial services provider’s stock worth $70,000 after purchasing an additional 198 shares in the last quarter. 78.07% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on HLI. Wells Fargo & Company raised shares of Houlihan Lokey from an “underweight” rating to an “overweight” rating and reduced their price target for the stock from $180.00 to $179.00 in a research report on Tuesday. Morgan Stanley increased their price target on shares of Houlihan Lokey from $200.00 to $201.00 and gave the stock an “underweight” rating in a research report on Wednesday, January 29th. StockNews.com lowered shares of Houlihan Lokey from a “buy” rating to a “hold” rating in a research report on Tuesday, February 25th. Keefe, Bruyette & Woods reissued a “market perform” rating and issued a $192.00 price target (up from $170.00) on shares of Houlihan Lokey in a research report on Wednesday, January 29th. Finally, JPMorgan Chase & Co. cut their price objective on shares of Houlihan Lokey from $172.00 to $169.00 and set a “neutral” rating on the stock in a research report on Wednesday, January 29th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $194.20.

Houlihan Lokey Stock Up 2.0 %

Shares of HLI stock opened at $157.49 on Wednesday. Houlihan Lokey, Inc. has a 12 month low of $121.81 and a 12 month high of $192.10. The business’s 50 day moving average is $174.95 and its two-hundred day moving average is $171.99. The company has a market cap of $11.05 billion, a PE ratio of 30.06 and a beta of 0.72.

Houlihan Lokey (NYSE:HLI) last announced its quarterly earnings results on Tuesday, January 28th. The financial services provider reported $1.64 EPS for the quarter, beating the consensus estimate of $1.51 by $0.13. Houlihan Lokey had a return on equity of 20.04% and a net margin of 16.00%. As a group, equities analysts expect that Houlihan Lokey, Inc. will post 5.98 EPS for the current fiscal year.

Houlihan Lokey Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Saturday, March 15th. Stockholders of record on Monday, March 3rd will be paid a $0.57 dividend. The ex-dividend date is Monday, March 3rd. This represents a $2.28 annualized dividend and a dividend yield of 1.45%. Houlihan Lokey’s payout ratio is 43.51%.

Houlihan Lokey Company Profile

Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.